MedPath

Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight

Not Applicable
Completed
Conditions
Disease Associated Underweight
Interventions
Dietary Supplement: The ONS provided to the children intervention group will be a ready to drink age adapted oral nutrition supplement providing 1,5 kcal/ml
Registration Number
NCT02383329
Lead Sponsor
Dr. Michael Chourdakis
Brief Summary

The purpose of this study is to test whether the provision of ONS to malnourished children across Europe, in addition to standard counselling, will improve weight gain and other outcomes.

The hypothesis to be tested is:

• Supplementation with ONS in malnourished paediatric patients will lead to increased WFH gain, as well as less malnutrition related complications (e.g. infections).

Primary outcome • The change in BMI z-score over the intervention period of 3 months

Secondary outcomes

• The change in WFH-weight for height (z-scores) over the intervention period of 3 months

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
224
Inclusion Criteria
  1. Children treated at the participating paediatric centres during the study period (inpatients or outpatients)
  2. Age between 24 months to 12 years at inclusion
  3. WFH at inclusion <- 1,5 SD - >-2,5 SD (based on WHO) OR Decrease in WFH z-score of ≥1 SD within the last 3 months, and underlying disease with high risk of undernutrition
  4. Children who would be considered candidates for oral nutrition intervention (but do not need tube feeding)
  5. Written informed consent of parents/caregivers
Exclusion Criteria
  1. Children in need of intensive care

  2. Inability to consume ONS (e.g. major gastrointestinal dysfunction)

  3. Children, for whom normal nutrition intervention would be inappropriate (e.g. food intolerance, allergy)

  4. Use of parenteral feeding and/or enteral tube-feeding

  5. Severe edema (>0.5 cm pitting edema on the dorsum of the foot)

  6. Participation in another intervention study involving investigational or marketed products concomitantly or within two weeks prior to entry into the trial.

  7. Children having received enteral nutrition treatment for underweight in the previous month

  8. Oncology patients during chemo-, radio-therapy

  9. Expected hospital stay at inclusion longer than 7 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oral Nutritional Supplement (ONS)The ONS provided to the children intervention group will be a ready to drink age adapted oral nutrition supplement providing 1,5 kcal/mlDiet consultation for the child/family + ONS
Primary Outcome Measures
NameTimeMethod
BMI z-score3 months

The change in BMI z-score over the intervention period of 3 months

Secondary Outcome Measures
NameTimeMethod
Gastrointestinal complications3 months

Frequency of gastrointestinal complications (number of days with diarrhoea/vomiting as reported by carers). Other GI symptoms could be recorded, as potential reason for lower food intake

Weight change3 months

The change in WFH-weight for height (z-scores) over the intervention period of 3 months

Infectious complications3 months

Frequency of infectious complications (number of days with temperature \>38,5°C, number of infections requiring antibiotic use)

Hospital admissions3 months

Admission for hospital inpatient treatments (number of days of hospital stay, number of admissions)

Trial Locations

Locations (19)

Hospital Jeanne de Flandre, Pediatrics Department, CHRU

🇫🇷

Lille, France

CHU Tours

🇫🇷

Tours, France

Aristotle University of Thessaloniki, School of Medicine

🇬🇷

Thessaloniki, Greece

3rd Paediatric Dept, Hippokration Hospital, AUTH

🇬🇷

Thessaloniki, Greece

Mofid Children Hospital

🇮🇷

Tehran, Iran, Islamic Republic of

Department of Pediatrics, Women and Children's Division, Oslo University Hospital

🇳🇴

Oslo, Norway

Kazan State Medical University

🇷🇺

Kazan, Respublika Tatarstan, Russian Federation

Ankara University School of Medicine

🇹🇷

Ankara, Turkey

Russian Medical Academy of Postgraduate Education

🇷🇺

Moscow, Russian Federation

Dokuz Eylul University,

🇹🇷

Izmir, Inciralti-izmir, Turkey

Inönü University School of Medicine

🇹🇷

Inönü, Turkey

Children's Hospital Zagreb

🇭🇷

Zagreb, Croatia

Hacettepe University, Ankara

🇹🇷

Ankara, Turkey

1st Paediatric Dept, Hippokration Hospital, AUTH

🇬🇷

Thessaloniki, Greece

Agia Sofia Children's Hospital

🇬🇷

Athens, Greece

Tehran University of Medical Sciences Tehrān, Children Medical Center

🇮🇷

Tehran, Iran, Islamic Republic of

UZ Brussel

🇧🇪

Brussel, Belgium

Medical University of Warsaw

🇵🇱

Warszawa, Poland

The Children's Memorial Health Institute

🇵🇱

Warszawa, Poland

© Copyright 2025. All Rights Reserved by MedPath